D60: ICD10 Code for Acquired pure red cell aplasia [erythroblastopenia]

D60 refers to Acquired pure red cell aplasia [erythroblastopenia], a group of anemias that do not fall under typical nutritional or hemolytic categories. These include red cell aplasia, marrow failure, bleeding-induced anemia, and anemia related to chronic disease. Each has distinct etiologies and management strategies but shares a core disruption in red blood cell production or survival.

Symptoms

• Fatigue – From low hemoglobin and oxygen delivery
• Pallor – Especially visible in the skin and mucosa
• Shortness of breath – Particularly on exertion
• Rapid heartbeat – As the body compensates for anemia
• Weakness or dizziness – From low red cell count
• Bleeding symptoms – If associated with marrow failure
• Delayed healing or chronic illness signs – In anemia of chronic disease

Diagnosis

Diagnosis of Acquired pure red cell aplasia [erythroblastopenia] requires complete blood count (CBC), reticulocyte count, bone marrow biopsy (in marrow failure syndromes), iron studies, and inflammatory markers. Underlying causes such as chronic disease, hemorrhage, or autoimmune conditions must be identified for effective treatment.

ICD10 Code Usage

ICD10 code D60 is widely used in hematology, internal medicine, oncology, and critical care. It helps document non-nutritional and non-hereditary anemias in EHRs, insurance claims, and public health records, aiding clinical and financial continuity of care.

Related Codes

• D61 – Other aplastic anemias and other bone marrow failure syndromes
• D62 – Acute posthemorrhagic anemia
• D63 – Anemia in chronic diseases classified elsewhere
• D64 – Other anemias

FAQs

Q1: What is ICD10 code D60?
A: It represents Acquired pure red cell aplasia [erythroblastopenia], used to document non-nutritional, acquired, or secondary forms of anemia in clinical practice.

Q2: What are the main causes?
A: Blood loss, chronic diseases (e.g., cancer, kidney disease), autoimmune suppression of marrow, or unknown marrow failure mechanisms.

Q3: Are these anemias reversible?
A: Some are treatable or manageable, especially if the underlying cause is addressed. Others may require lifelong monitoring.

Q4: How are they treated?
A: Blood transfusions, immunosuppressants, erythropoietin, or treatment of the root condition (e.g., inflammation, infection).

Q5: Who manages these conditions?
A: Hematologists, internists, nephrologists, or oncologists depending on the cause and severity.

Conclusion

ICD10 code D60 enables clear classification and tracking of Acquired pure red cell aplasia [erythroblastopenia]. It supports personalized management, enables coding precision, and ensures that patients receive targeted evaluation and therapies based on the specific type of anemia.